Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Matinas BioPharma Nanotechnologies, Inc.
With
Matinas Biopharma, Inc
Midwest Biomedical Research
An open-label, randomized, crossover study to assess the pharmacodynamic effects of MAT-9001, an omega-3 free fatty acid compared to Vascepa (icosapent ethyl) on triglycerides and other lipoprotein lipids in men and women with elevated triglycerides.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, ≥18 y of age
Judged to be in generally good health
Fasting triglycerides ≥150 mg/dL to ≤499 mg/dL during screening
Body mass index of ≥20.0 kg/m2
No clinically significant findings in a 12-lead ECG or physical examination
Willing and able to undergo the scheduled study procedures
Understands study procedures and signs forms documenting informed consent to participate in the study
